A Phase II Study of AL-37807 to Treat Open-Angle Glaucoma or Ocular Hypertension
Sponsor
Alcon Research (Industry)
Overall Status
Completed
CT.gov ID
NCT00372931
Collaborator
(none)
120
1
Study Details
Study Description
Brief Summary
The purpose of this study is to determine whether AL-37807 is safe and effective in treating patients with open-angle glaucoma or ocular hypertension
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
| Phase 2 |
Study Design
Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Treatment
Official Title:
A Phase II Study of AL-37807 to Treat Open-Angle Glaucoma or Ocular Hypertension
Study Start Date
:
May 1, 2006
Actual Primary Completion Date
:
Aug 1, 2007
Outcome Measures
Primary Outcome Measures
- Mean IOP change from baseline []
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Adult patients of either sex and any race with open-angle glaucoma or ocular hypertension; logMAR visual acuity not worse than 0.60; additionally clinically relevant ophthalmic or systemic conditions may be excluded
Exclusion Criteria:
- Under 18
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | San Antonio Site | San Antonio | Texas | United States | 78240 |
Sponsors and Collaborators
- Alcon Research
Investigators
- Study Director: Theresa Landry, Study Director
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00372931
Other Study ID Numbers:
- C-06-15
First Posted:
Sep 7, 2006
Last Update Posted:
Apr 22, 2008
Last Verified:
Apr 1, 2008